Stephanie Aungst

1.1k total citations
8 papers, 698 citations indexed

About

Stephanie Aungst is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stephanie Aungst has authored 8 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stephanie Aungst's work include Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). Stephanie Aungst is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). Stephanie Aungst collaborates with scholars based in United States. Stephanie Aungst's co-authors include Alan I. Faden, Scott M. Thompson, Marta M. Lipinski, Zaorui Zhao, Boris Sabirzhanov, Chinmoy Sarkar, Bogdan A. Stoica, Shruti V. Kabadi, Richard Pazdur and Hong Zhao and has published in prestigious journals such as Journal of Neurophysiology, Clinical Cancer Research and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Stephanie Aungst

8 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Aungst United States 8 287 265 228 113 87 8 698
Masahiro Tsubaki Japan 18 169 0.6× 217 0.8× 218 1.0× 148 1.3× 205 2.4× 52 923
Chunlong Zhong China 18 174 0.6× 410 1.5× 155 0.7× 74 0.7× 70 0.8× 57 961
Yujian Zhang China 14 151 0.5× 403 1.5× 150 0.7× 252 2.2× 124 1.4× 26 900
Hidetoshi Ooigawa Japan 17 114 0.4× 371 1.4× 333 1.5× 64 0.6× 111 1.3× 61 1.0k
Meng Cheong Wong Singapore 16 188 0.7× 212 0.8× 93 0.4× 66 0.6× 109 1.3× 28 822
R. Christian Crumrine United States 14 146 0.5× 356 1.3× 249 1.1× 122 1.1× 72 0.8× 19 904
Honglu Chao China 20 247 0.9× 785 3.0× 257 1.1× 77 0.7× 299 3.4× 31 1.3k
Jianzhong Cui China 15 122 0.4× 260 1.0× 187 0.8× 23 0.2× 63 0.7× 31 576
Kazuhide Furuya Japan 16 100 0.3× 221 0.8× 252 1.1× 37 0.3× 98 1.1× 27 841
Ali Sazcı Türkiye 19 156 0.5× 255 1.0× 87 0.4× 70 0.6× 27 0.3× 42 993

Countries citing papers authored by Stephanie Aungst

Since Specialization
Citations

This map shows the geographic impact of Stephanie Aungst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Aungst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Aungst more than expected).

Fields of papers citing papers by Stephanie Aungst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Aungst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Aungst. The network helps show where Stephanie Aungst may publish in the future.

Co-authorship network of co-authors of Stephanie Aungst

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Aungst. A scholar is included among the top collaborators of Stephanie Aungst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Aungst. Stephanie Aungst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mehta, Gautam U., Paz J. Vellanki, Yi Ren, et al.. (2024). FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations. The Oncologist. 29(8). 667–671. 10 indexed citations
2.
Larkins, Erin, Pallavi S. Mishra‐Kalyani, Stephanie Aungst, et al.. (2023). FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical Cancer Research. 29(17). 3262–3266. 33 indexed citations
3.
Marcus, Leigh, Martha Donoghue, Stephanie Aungst, et al.. (2020). FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors. Clinical Cancer Research. 27(4). 928–932. 92 indexed citations
4.
Nair, Abhilasha, Steven J. Lemery, Jun Yang, et al.. (2015). FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine–Refractory Differentiated Thyroid Cancer. Clinical Cancer Research. 21(23). 5205–5208. 64 indexed citations
5.
Sarkar, Chinmoy, Zaorui Zhao, Stephanie Aungst, et al.. (2014). Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy. 10(12). 2208–2222. 261 indexed citations
6.
Aungst, Stephanie, Shruti V. Kabadi, Scott M. Thompson, Bogdan A. Stoica, & Alan I. Faden. (2014). Repeated Mild Traumatic Brain Injury Causes Chronic Neuroinflammation, Changes in Hippocampal Synaptic Plasticity, and Associated Cognitive Deficits. Journal of Cerebral Blood Flow & Metabolism. 34(7). 1223–1232. 197 indexed citations
7.
Aungst, Stephanie, Pamela M. England, & Scott M. Thompson. (2012). Critical role of trkB receptors in reactive axonal sprouting and hyperexcitability after axonal injury. Journal of Neurophysiology. 109(3). 813–824. 19 indexed citations
8.
Dinocourt, Céline, Stephanie Aungst, Kun Yang, & Scott M. Thompson. (2011). Homeostatic increase in excitability in area CA1 after Schaffer collateral transection in vivo. Epilepsia. 52(9). 1656–1665. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026